OTC · NUNZ
Nunzia Pharmaceutical Company
Healthcare · Drug Manufacturers - Specialty & Generic
$0.00
Up+$0.00 (+0.00%)
Updated Nov 3, 2026, 12:41 PM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 43.45K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $0.00 – $0.00
- Volume
- 1.75K
- Avg. volume
- 15
Price performance · NUNZ
NUNZ price history
1M range · 1 trading sessions · Daily adjusted prices
Prices through Oct 15, 2026
NUNZ closed at $0.00 after 1 trading sessions, up 0.00% for the selected period.
No results
At least two price observations are needed to draw this chart.
Latest NUNZ news
The latest Smart Investors Daily articles mentioning NUNZ.
Stock researchCompany · Overview
Company
Market Activity
Research & News
NUNZ research
Overview
Company profile and research snapshot.
Company profile
NUNZIA PHARMACEUTICL CORP
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
